Insider Trading March 31, 2026

Universal Insurance Director Sells $68k in UVE Stock; Company Posts Strong EPS Beat in Q4 2025

Director Richard D. Peterson trimmed his stake as Universal Insurance stock trades near its 52-week high following a double-digit surge over the past year

By Derek Hwang UVE
Universal Insurance Director Sells $68k in UVE Stock; Company Posts Strong EPS Beat in Q4 2025
UVE

Universal Insurance Holdings director Richard D. Peterson sold 2,000 shares on March 30, 2026, generating roughly $68,207 in proceeds at prices between $34.06 and $34.14 per share. The transaction occurred while UVE shares trade near a 52-week high and after the company reported a sizable earnings-per-share beat for the fourth quarter of 2025, even as revenue fell slightly short of expectations.

Key Points

  • Director Richard D. Peterson sold 2,000 UVE shares on March 30, 2026, for about $68,207 at $34.06 to $34.14 per share.
  • After the sale Peterson owns 19,136 shares directly and 6,319 indirectly through The RDP Revocable Trust dated August 11, 2011.
  • Universal Insurance reported Q4 2025 EPS of $2.17 versus an expected $0.94 (a 130.85% surprise), while revenue was $483.68 million versus $485.02 million expected.

Richard D. Peterson, a director at Universal Insurance Holdings (NYSE: UVE), executed an open-market sale of 2,000 common shares on March 30, 2026, for approximately $68,207. The shares changed hands at prices ranging from $34.06 to $34.14 per share.

The sale took place amid a strong run for UVE stock; shares have risen 48% over the prior 12 months and were quoted at $34.16, trading close to a 52-week high of $36.68.

Following the disposition, Peterson directly holds 19,136 shares of Universal Insurance Holdings. In addition, he maintains an indirect interest of 6,319 shares through The RDP Revocable Trust dated August 11, 2011, in which he serves as grantor and sole trustee and his children are named as beneficiaries.


Valuation and analyst context

On valuation metrics, UVE is trading at a price-to-earnings ratio of 5.39. According to InvestingPro analysis referenced in company reporting, the stock appears undervalued based on Fair Value measurements. The firm also notes that a comprehensive Pro Research Report covering UVE is available, along with reports for more than 1,400 other U.S. equities.


Recent financial results

Universal Insurance Holdings released fourth-quarter 2025 results showing an earnings-per-share (EPS) of $2.17, substantially ahead of the expected $0.94. That gap represents a 130.85% earnings surprise relative to consensus estimates. Revenue for the quarter was $483.68 million, narrowly missing the expected $485.02 million.

Analysts have been reviewing the quarter's performance, though no specific upgrades or downgrades from major firms have been reported at this time. Market participants are monitoring how the strong EPS outcome, paired with a modest revenue shortfall, factors into broader assessments of the company's operating performance and valuation.


What this means

The insider sale by a company director occurred while shares trade near multi-month highs and after a quarter that delivered a significant EPS beat alongside a slight revenue miss. Peterson's retained direct and indirect holdings mean he remains a meaningful shareholder following the transaction.

Investors and market observers will likely weigh the insider transaction alongside recent earnings data and the stock's low P/E when forming views on Universal Insurance's near-term outlook.

Risks

  • Insider sale - While the director retains sizeable direct and indirect holdings, an insider sale can create short-term uncertainty among shareholders - impacts the financials and insurance sectors.
  • Revenue shortfall - The company reported revenue slightly below expectations, which introduces some near-term execution risk despite a strong EPS beat - impacts the insurance and broader financial services sectors.
  • Analyst activity uncertain - No specific upgrades or downgrades from major firms have been reported following the results, leaving near-term analyst sentiment and guidance reactions unclear - impacts investor sentiment in the financials sector.

More from Insider Trading

ArrowMark Financial Director Buys 1,500 Shares as Company Launches Rights Offering Mar 31, 2026 Strawberry Fields REIT Director Acquires $17,465 Stake; Company Announces Dividend and Executive Pay Changes Mar 31, 2026 Edgewise Therapeutics CMO Disposes Shares While Exercising Options Amid Positive Trial News Mar 31, 2026 Platinum Equity Disposes of 1.35M Ingram Micro Shares in $28.8M Trade Mar 31, 2026 Adaptive Biotechnologies President Disposes of $751k in Stock While Exercising Options Mar 31, 2026